PREDICT Plus: a population-based validation of a prognostic model for early breast cancer that includes HER2

Background and Purpose: Predict (www.predict.nhs.uk) is an online, breast cancer prognostication and treatment benefit tool developed using�UK cancer registration data. The aim was to estimate the prognostic effect of HER2 status, include it in a new version of the model (Predict+), and to compare the 10-year survival estimates from Predict+ with the original Predict model, Adjuvant! and the observed 10-year outcome from a British Columbia dataset used previously to validate Predict and Adjuvant!. (Source: The Breast)

schools for phlebotomy phlebotomy training in michigan local phlebotomy classes